Cargando…

T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease

BACKGROUND: There are increased numbers of activated lymphocytes in the lungs of chronic obstructive pulmonary disease (COPD) patients. The clinical benefits of corticosteroids in COPD patients are limited. Our hypothesis is that lymphocytes play a role in this corticosteroid insensitivity. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Manminder, Smyth, Lucy JC, Cadden, Paul, Grundy, Seamus, Ray, David, Plumb, Jonathan, Singh, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320534/ https://www.ncbi.nlm.nih.gov/pubmed/22417244 http://dx.doi.org/10.1186/1465-9921-13-20

Ejemplares similares

Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells
por: Grundy, Seamus, et al.
Publicado: (2016)

Down Regulation of T Cell Receptor Expression in COPD Pulmonary CD8 Cells
por: Grundy, Seamus, et al.
Publicado: (2013)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
por: Xie, Tao, et al.
Publicado: (2023)

The role of the liver X receptor in chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2013)

Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi
por: Khalaf, Rana M., et al.
Publicado: (2017)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Han, MeiLan K., et al.
Publicado: (2021)

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
por: Marwick, John A, et al.
Publicado: (2010)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
por: Singh, Sonal, et al.
Publicado: (2010)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

The effects of corticosteroids on COPD lung macrophages: a pooled analysis
por: Higham, Andrew, et al.
Publicado: (2015)

Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD
por: Lewis, Brandon W., et al.
Publicado: (2021)

Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
por: Woods, J Andrew, et al.
Publicado: (2014)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

Aging-Related Mechanisms Contribute to Corticosteroid Insensitivity in Elderly Asthma
por: Ford, Maria L., et al.
Publicado: (2023)

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm
por: Wilkie, Morven, et al.
Publicado: (2015)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Chronic Allergen Challenge Induces Corticosteroid Insensitivity With Persistent Airway Remodeling and Type 2 Inflammation
por: Lewis, Brandon W., et al.
Publicado: (2022)

Characterization of T Lymphocytes in Chronic Obstructive Pulmonary Disease
por: Barnes, Peter J, et al.
Publicado: (2004)

Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury
por: Pinart, Mariona, et al.
Publicado: (2014)

Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease
por: Khadka, Priyatam, et al.
Publicado: (2018)

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
por: Milara, Javier, et al.
Publicado: (2018)

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Reigniting the TORCH: Chronic Obstructive Pulmonary Disease Mortality and Inhaled Corticosteroids Revisited
por: Calverley, Peter
Publicado: (2021)

The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review
por: Williams, Maya, et al.
Publicado: (2020)

The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease
por: Gao, Shupei, et al.
Publicado: (2020)

Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease
por: Singh, Dave
Publicado: (2017)

Cyclin D1 in ASM Cells from Asthmatics Is Insensitive to Corticosteroid Inhibition
por: Allen, Jodi C., et al.
Publicado: (2012)

Defects of Protein Phosphatase 2A Causes Corticosteroid Insensitivity in Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2011)

Evaluation of a novel method to assess corticosteroid responsiveness in chronic obstructive pulmonary disease
por: Al-Ghimlas, Fahad A, et al.
Publicado: (2010)

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease
por: Horita, Nobuyuki, et al.
Publicado: (2014)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2017)

Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease
por: Mitani, Akihisa, et al.
Publicado: (2017)

Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
por: Irusen, Elvis M., et al.
Publicado: (2020)

Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
por: Chiu, Kai-Lin, et al.
Publicado: (2021)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and COVID-19: interrelationships
por: Singh, Dave, et al.
Publicado: (2022)

Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil–to–lymphocyte ratio, and mortality outcomes in US adults
por: Hu, Han-Shuo, et al.
Publicado: (2023)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_98pmn1tfc9gvl7l2demeaek22p